Extended-spectrum beta-lactamases producing extensively drug-resistant Salmonella Typhi in Punjab, Pakistan

被引:24
|
作者
Saeed, Muhammad [1 ]
Rasool, Muhammad Hidayat [1 ]
Rasheed, Farhan [2 ]
Saqalein, Muhammad [1 ]
Nisar, Muhammad Atif [1 ]
Imran, Ambreen Anwar [2 ]
Tariq, Saba [3 ]
Amir, Afreenish [4 ]
Ikram, Aamer [4 ]
Khurshid, Mohsin [1 ]
机构
[1] Govt Coll Univ Faisalabad, Dept Microbiol, Liaquat Block,New Campus,Jhang Rd, Faisalabad 38000, Pakistan
[2] Allama Iqbal Med Coll, Dept Pathol, Lahore, Pakistan
[3] Univ Punjab, Ctr Appl Mol Biol, Lahore, Pakistan
[4] Natl Inst Hlth, Islamabad, Pakistan
来源
关键词
Salmonella; cephalosporins; ESBL; typhoid; ENTERICA SEROVAR TYPHI; SUSCEPTIBILITY; STRAIN; FEVER;
D O I
10.3855/jidc.12049
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The multidrug-resistant (MDR) Salmonella enterica serovar Typhi isolates have been increasingly reported from the Asian and African countries. The emergence of isolates with decreased susceptibility to fluoroquinolones and cephalosporins has worsened the situation. Recently, an outbreak from Sindh, Pakistan was reported caused by extensively drug-resistant (XDR) S. Typhi strains. Methodology: In the present study, a total of 82 cases of typhoid have been investigated during 2018 from the febrile children referred to a tertiary care hospital in the population-wise largest province (Punjab) of Pakistan. S. Typhi was identified by standard microbiological techniques and isolates were characterized for antimicrobial resistance profiling and minimum inhibitory concentrations were determined. The presence of various ESBL genes in S. Typhi was confirmed by the PCR. Results: Out of the 82 isolates tested, 35 (43%) were found to be XDR; resistant to the first-line drugs. The resistance to third-generation cephalosporins was mainly mediated by extended-spectrum beta-lactamases i.e. blaTEM and blaCTX-M genes. Conclusions: The higher prevalence of ESBL producing Salmonella typhi clinical strains raises the concern about transmission prevention and infection management in the community as well as clinical settings. Moreover, the study highlights the problem concerning the declining antibiotic arsenal for the therapeutic management of typhoid fever and the emergence and spread of XDR strains in Pakistan.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [41] Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum beta-lactamases and/or AmpC beta-lactamases in food and food-producing animals
    Andreoletti, Olivier
    Budka, Herbert
    Buncic, Sava
    Collins, John D.
    Griffin, John
    Hald, Tine
    Havelaar, Arie Hendric
    Hope, James
    Klein, Guenter
    Koutsumanis, Kostas
    McLauchlin, James
    Mueller-Graf, Christine
    Nguyen-The, Christophe
    Noerrung, Birgit
    Peixe, Luisa
    Maradona, Miguel Prieto
    Ricci, Antonia
    Sofos, John
    Threlfall, John
    Vagsholm, Ivar
    Vanopdenbosch, Emmanuel
    EFSA JOURNAL, 2011, 9 (08)
  • [42] Occurrence of extended-spectrum beta-lactamases (ESBL) in Dutch hospitals
    Stobberingh, EE
    Arends, J
    Hoogkamp-Korstanje, JAA
    Goessens, WHF
    Visser, MR
    Buiting, AGM
    Debets-Ossenkopp, YJ
    van Ketel, RJ
    van Ogtrop, ML
    Sabbe, LJM
    Voorn, GP
    Winter, HLJ
    van Zeijl, JH
    INFECTION, 1999, 27 (06) : 348 - 354
  • [43] Extended-spectrum beta-lactamases, what is the risk in pediatric oncology?
    Legeay, C.
    Hilliquin, D.
    Brunet, M.
    Zahar, J. -R.
    REVUE D ONCOLOGIE HEMATOLOGIE PEDIATRIQUE, 2016, 4 (01): : 25 - 34
  • [44] PROPERTIES OF PLASMIDS RESPONSIBLE FOR PRODUCTION OF EXTENDED-SPECTRUM BETA-LACTAMASES
    JACOBY, GA
    SUTTON, L
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) : 164 - 169
  • [45] Extended-spectrum beta-lactamases screening agar with AmpC inhibition
    Al Naiemi, N.
    Murk, J. L.
    Savelkoul, P. H. M.
    Vandenbroucke-Grauls, C. M. J.
    Debets-Ossenkopp, Y. J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (08) : 989 - 990
  • [46] Extended-spectrum beta-lactamases in Dubrovnik-neretva county
    Krilanovic, M.
    Bedenic, B.
    Car, H.
    Francula-Zaninovic, S.
    Beader, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 79 : 48 - 48
  • [47] Extended-spectrum beta-lactamases screening agar with AmpC inhibition
    N. Al Naiemi
    J. L. Murk
    P. H. M. Savelkoul
    C. M. J. Vandenbroucke-Grauls
    Y. J. Debets-Ossenkopp
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 989 - 990
  • [48] THE FREQUENCY OF EXTENDED-SPECTRUM BETA-LACTAMASES IN ISOLATES OF KLEBSIELLA PNEUMONIAE
    KATSANIS, G
    JACOBY, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) : 345 - 346
  • [49] Prevalence, resistance, and extended-spectrum beta-lactamases among Salmonella from patients in northeast China
    Zhang, Zhijie
    Wang, Xingning
    Li, Ruihua
    Xue, Wencheng
    Zhai, Rubo
    Liu, Liwen
    Liu, Yong
    Jin, Hong
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2017, 11 (06): : 470 - 478
  • [50] Screening of Extended-Spectrum beta-Lactamases (ESBL)-producing Klebsiella pneumoniae with ChromID ESBL Media
    Noerwidayati, Emy
    Dahesihdewi, Andaru
    Sianipar, Osman
    INDONESIAN BIOMEDICAL JOURNAL, 2018, 10 (03): : 217 - 221